An epigenetic blueprint reveals how aggressive MYC amplification fuels cancer
Researchers at the Cancer Epigenetics Institute (CEI) at Fox Chase Cancer Center have discovered how to control and stop the amplification of MYC—one of the most commonly altered cancer genes linked to aggressive tumor growth and treatment resistance.
Read original article on Medical Xpress - latest medical and health news stories →Related news
-
Stem cell-derived brain models offer a new window into how anesthesia works
United Kingdom
-
Study reveals large gaps in care for youths with opioid use disorder
United Kingdom
-
Moms overcome barriers to postpartum care with help from patient navigators
United Kingdom
-
Tirzepatide cuts fat mass by 35% while preserving skeletal muscle
United Kingdom
-
Magnetically controlled capsule shows promise for investigating hard-to-reach regions of the small intestine
United Kingdom
-
Eating walnuts daily may boost mood and shift serotonin-related metabolism
United Kingdom
-
Mass spectrometry offers faster look at the edges of brain tumors
United Kingdom
-
Could the gut be priming the body for a more severe stroke?
United Kingdom